The FDA has approved Moderna's $Moderna, Inc.(MRNA)$ 2026-2027 COVID formulas. The agency signed off on supplemental biologics license applications for updated versions of Spikevax and mNEXSPIKE, with the vaccines expected to be available in the coming days. The updated Spikevax formula is approved for individuals 6 months through 64 years of age with at least one underlying condition.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
